Sarah Sammons, MD, discusses some of the challenges seen with different regimens for HER2-positive metastatic breast cancer ...
Reid Merryman, MD, discusses which patients are typically monitored for minimal residual disease and whether there are ...
ENGOT-cx11 is a randomized, double-blind, placebo-controlled trial that enrolled patients aged 18 years or older diagnosed ...
A recent Targeted Oncology survey explores the challenges and best practices in transitioning patients with cancer from inpatient to outpatient care, featuring insights from Cristina Gasparetto, MD, ...
LBS-007, a novel targeted therapy, has received FDA fast track designation for the treatment of acute myeloid leukemia.
The open-label portion of the phase 1b/2 ASIST study (NCT05322590) evaluating the combination of BXQ-350 plus standard of care (SOC) for the first-line treatment of patients with metastatic colorectal ...
Samer A. Al’Hadidi, MD, discusses factors influencing early use of chimeric antigen receptor T-cell therapy in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback